‘London Is Open: Round Table Hifghlights' from Cannabis Europa and Prohibition Partners explores the process involved for cannabis companies looking to list on the London stock markets.

‘London Is Open: Part 2' from Cannabis Europa and Prohibition Partners explores the process involved for cannabis companies looking to list on the London stock markets.

‘London Is Open: Part 2' from Cannabis Europa and Prohibition Partners explores the process involved for cannabis companies looking to list on the London stock markets.

‘London Is Open: Part 2' from Cannabis Europa and Prohibition Partners explores the process involved for cannabis companies looking to list on the London stock markets.

‘London Is Open’ is a three-part series from Cannabis Europa and Prohibition Partners exploring the promising opportunities for successful medicinal cannabis and CBD companies listing on the London stock markets this year.

Ronnie Cowan is an MP for the Scottish National Party and represents Inverclyde in the House of Commons. Having been first elected in 2015, Mr Cowan has campaigned for a number of key social issues including drug policy reform, with a strong focus on improving access to medical cannabis.

Shimadzu is one of the world’s leading providers of analytical instruments for applications in a broad range of industries. In the United States, Shimadzu has been at the forefront of working with cannabis testing laboratories from the start, and has a comprehensive understanding of the requirements of this evolving industry.

Returning to Britain’s capital city for the third year in a row, Cannabis Europa London invites you to join policymakers, industry pioneers, and scientific innovators from the four corners of the globe at London’s iconic Southbank Centre on June 22 - 23, 2020, to discuss and shape the future of medical cannabis in Europe.

Shimadzu is one of the world’s leading providers of analytical instruments for applications in a broad range of industries. In the United States, Shimadzu has been at the forefront of working with cannabis testing laboratories from the start, and has a comprehensive understanding of the requirements of this evolving industry.

Brains Bioceutical Corp ("Brains") is a leader in the good manufacturing practice (GMP) certified production of naturally-sourced active pharmaceutical ingredients for the pharmaceutical and nutraceutical industries. Brains Bioceutical is one of the only cannabinoid active pharmaceutical ingredient (API) manufacturers in production today.

Almirall is a leading skin-health focused global pharmaceutical company that partners with healthcare professionals, applying science to provide medical solutions to patients and future generations. Almirall is focused on fighting skin health diseases and helping people feel better.

Baker Tilly is a full-service firm that seeks to generate longstanding relations by providing bespoke and reliable support to clients as cross-wise corporate advisors. As a US$3.6 billion global organisation with member firms in more than 145 territories, Baker Tilly boasts the scale to meet their clients’ ever-changing needs, and the agility to help them stay one step ahead.

Baker Tilly is a full-service firm that seeks to generate longstanding relations by providing bespoke and reliable support to clients as cross-wise corporate advisors. As a US$3.6 billion global organisation with member firms in more than 145 territories, Baker Tilly boasts the scale to meet their clients’ ever-changing needs, and the agility to help them stay one step ahead.

Synoptis Industrial is a European Good Manufacturing Practice (EU GMP) certified pharmaceutical importer, packing, and Qualified Person (QP) certification site, headquartered in Toruń, Poland. The company provides full end-to-end supply chain services, delivering products to clients across the EU. Synoptis Industrial carries a wealth of experience in dealing with the import and export of regular and controlled pharmaceutical products.

Epperly | Elam is a San Francisco-based law firm, founded on the premise that law should be used as a proactive measure to explore opportunities for clients, rather than just as a way of solving problems when they arise. Since the firm’s inception, they have provided California’s early cannabis pioneers with the expert legal support needed to navigate the ever-fluctuating field of cannabis regulations. 

Headquartered in Berlin, Germany, Aurora Europe is one of the largest authorised importers and distributors of medical cannabis in the European Union. Aurora Europe is a subsidiary of the publicly listed cannabis producer, Aurora Cannabis Inc., which is headquartered in Edmonton, Alberta, Canada, with sales and operations across five continents and 25 countries, including Aurora Medicine España.

Cannabis Europa will arrive in Spain for the first time on February 10th 2020, helping to drive forward legislation in one of Europe’s most promising potential cannabis markets. Unlike many of its European neighbours, Spain has yet to formally legalise cannabis, though the personal possession and private use of the drug is decriminalised.

The intimate and exclusive meeting was held at the historic Metropolitan Club in New York City, frequented by the political and business elite, including founding members JP Morgan, James A. Roosevelt and William Kissam Vanderbilt. European governments and C-Suite decision makers gathered to discuss transatlantic cooperation joining the investors and financiers who turned out to access the inside track on medical cannabis’s most promising European opportunities.

Hosted at the iconic Fairmont Royal York, set against a stunning urban Canadian backdrop, the conference opened up the conversation on how to achieve greater transatlantic cooperation and equipped North American firms with practical insights on how to capitalise on the burgeoning European market.

Grow Biotech is a British company that develops revolutionary processes, practices, techniques, tools and formulations in order to unlock the medical potential of cannabis for those who need it. Grow Biotech’s market access team is involved in launching medical cannabis producers’ businesses into new markets and their R&D team creates new technologies that support the producers so they create better, more cost-effective and readily available medicines.